ARTIFICIAL SURFACTANT

Survanta dosing should be every 6-12 hours for three doses. The frequency of dosing and the total number of doses is at the discretion of the attending Neonatologist. Rapid response may mean that additional improvement would not be expected and therefore additional doses would not be required; conversely, if there is an unfavorable response to the first dose or if the patient is "too unstable" to tolerate dosing, additional doses might not be given. Therefore the attending Neonatologist should make the decision about additional doses after the initial dose.

INDICATIONS

Prophylactic use

Rescue use

Possible Indications for Rescue use

  1. Diaphragmatic hernia
  2. Established respiratory failure from meconium aspiration
  3. Established respiratory failure from pneumonia
  4. Atypical or intractable respiratory failure
  5. Adult respiratory distress syndrome in non-neonatal patients
  6. Intractable respiratory failure in non-neonatal patients


previous page | next page